JP2009506066A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009506066A5 JP2009506066A5 JP2008528168A JP2008528168A JP2009506066A5 JP 2009506066 A5 JP2009506066 A5 JP 2009506066A5 JP 2008528168 A JP2008528168 A JP 2008528168A JP 2008528168 A JP2008528168 A JP 2008528168A JP 2009506066 A5 JP2009506066 A5 JP 2009506066A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- unsaturated
- aromatic
- group
- saturated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 120
- 229920006395 saturated elastomer Polymers 0.000 claims 106
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 claims 103
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 86
- 125000003118 aryl group Chemical group 0.000 claims 81
- 229910052760 oxygen Inorganic materials 0.000 claims 70
- 229910052757 nitrogen Inorganic materials 0.000 claims 66
- 239000001301 oxygen Substances 0.000 claims 63
- 229910052717 sulfur Inorganic materials 0.000 claims 63
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 62
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 57
- 239000011593 sulfur Substances 0.000 claims 56
- 150000001875 compounds Chemical class 0.000 claims 55
- 125000005842 heteroatom Chemical group 0.000 claims 54
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 32
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 28
- 125000000623 heterocyclic group Chemical group 0.000 claims 28
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 27
- 125000000304 alkynyl group Chemical group 0.000 claims 27
- 150000002148 esters Chemical class 0.000 claims 27
- 239000000651 prodrug Substances 0.000 claims 27
- 229940002612 prodrug Drugs 0.000 claims 27
- 150000003839 salts Chemical class 0.000 claims 27
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 24
- 125000004429 atom Chemical group 0.000 claims 24
- 229910052799 carbon Inorganic materials 0.000 claims 22
- 125000001072 heteroaryl group Chemical group 0.000 claims 21
- 125000003342 alkenyl group Chemical group 0.000 claims 20
- 150000001204 N-oxides Chemical class 0.000 claims 19
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 17
- 239000000203 mixture Substances 0.000 claims 17
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 15
- 229910052736 halogen Inorganic materials 0.000 claims 14
- 150000002367 halogens Chemical class 0.000 claims 14
- 125000003545 alkoxy group Chemical group 0.000 claims 12
- 125000002252 acyl group Chemical group 0.000 claims 11
- 229910052731 fluorine Inorganic materials 0.000 claims 11
- 229910052739 hydrogen Inorganic materials 0.000 claims 10
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 9
- 241000124008 Mammalia Species 0.000 claims 8
- 125000003107 substituted aryl group Chemical group 0.000 claims 8
- 229910052794 bromium Inorganic materials 0.000 claims 7
- 229910052801 chlorine Inorganic materials 0.000 claims 7
- 229910052740 iodine Inorganic materials 0.000 claims 7
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 208000015181 infectious disease Diseases 0.000 claims 5
- 239000003120 macrolide antibiotic agent Substances 0.000 claims 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 150000001336 alkenes Chemical class 0.000 claims 4
- 125000004414 alkyl thio group Chemical group 0.000 claims 4
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 4
- 230000000813 microbial effect Effects 0.000 claims 4
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims 4
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 3
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 3
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 3
- 125000005841 biaryl group Chemical group 0.000 claims 3
- 125000002619 bicyclic group Chemical group 0.000 claims 3
- 150000001721 carbon Chemical group 0.000 claims 3
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 2
- 108020004485 Nonsense Codon Proteins 0.000 claims 2
- 206010062255 Soft tissue infection Diseases 0.000 claims 2
- 125000002837 carbocyclic group Chemical group 0.000 claims 2
- 150000002016 disaccharides Chemical class 0.000 claims 2
- 125000006575 electron-withdrawing group Chemical group 0.000 claims 2
- 150000002118 epoxides Chemical class 0.000 claims 2
- 150000002337 glycosamines Chemical class 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 150000002772 monosaccharides Chemical class 0.000 claims 2
- 230000035772 mutation Effects 0.000 claims 2
- 230000037434 nonsense mutation Effects 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 206010040872 skin infection Diseases 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 208000037041 Community-Acquired Infections Diseases 0.000 claims 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
- 206010017533 Fungal infection Diseases 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 claims 1
- GDIHDSKOVXEJQQ-UHFFFAOYSA-N NC(O)=O.NC(O)=O.NC(O)=O.N Chemical compound NC(O)=O.NC(O)=O.NC(O)=O.N GDIHDSKOVXEJQQ-UHFFFAOYSA-N 0.000 claims 1
- 208000030852 Parasitic disease Diseases 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 229910021386 carbon form Inorganic materials 0.000 claims 1
- 239000003610 charcoal Substances 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000003700 epoxy group Chemical group 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 230000004899 motility Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
- 0 CC(*)(*)N[C@@](*)(CN(C)C12)[C@]1(*)[C@@](*)(C(*)SC)OC2(I)I Chemical compound CC(*)(*)N[C@@](*)(CN(C)C12)[C@]1(*)[C@@](*)(C(*)SC)OC2(I)I 0.000 description 7
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71144305P | 2005-08-24 | 2005-08-24 | |
| US76290706P | 2006-01-26 | 2006-01-26 | |
| PCT/US2006/033170 WO2007025098A2 (en) | 2005-08-24 | 2006-08-24 | Triazole compounds and methods of making and using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009506066A JP2009506066A (ja) | 2009-02-12 |
| JP2009506066A5 true JP2009506066A5 (https=) | 2009-10-08 |
Family
ID=37467427
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008528247A Expired - Fee Related JP5395432B2 (ja) | 2005-08-24 | 2006-08-24 | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
| JP2008528168A Withdrawn JP2009506066A (ja) | 2005-08-24 | 2006-08-24 | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
| JP2013169594A Expired - Fee Related JP5981401B2 (ja) | 2005-08-24 | 2013-08-19 | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
| JP2015223733A Pending JP2016094421A (ja) | 2005-08-24 | 2015-11-16 | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
| JP2017141745A Pending JP2018008970A (ja) | 2005-08-24 | 2017-07-21 | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
| JP2018169395A Pending JP2019023194A (ja) | 2005-08-24 | 2018-09-11 | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008528247A Expired - Fee Related JP5395432B2 (ja) | 2005-08-24 | 2006-08-24 | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013169594A Expired - Fee Related JP5981401B2 (ja) | 2005-08-24 | 2013-08-19 | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
| JP2015223733A Pending JP2016094421A (ja) | 2005-08-24 | 2015-11-16 | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
| JP2017141745A Pending JP2018008970A (ja) | 2005-08-24 | 2017-07-21 | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
| JP2018169395A Pending JP2019023194A (ja) | 2005-08-24 | 2018-09-11 | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (5) | US8278281B2 (https=) |
| EP (3) | EP3290427A1 (https=) |
| JP (6) | JP5395432B2 (https=) |
| DK (1) | DK1934238T3 (https=) |
| ES (1) | ES2638427T3 (https=) |
| HR (1) | HRP20171285T1 (https=) |
| WO (2) | WO2007025284A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5383037B2 (ja) | 2004-02-27 | 2014-01-08 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | 大環状化合物およびそれらを製造し使用する方法 |
| JP2009506063A (ja) | 2005-08-24 | 2009-02-12 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
| EP3290427A1 (en) * | 2005-08-24 | 2018-03-07 | Melinta Therapeutics, Inc. | Triazole compounds and methods of making and using the same |
| WO2008106224A1 (en) * | 2007-02-28 | 2008-09-04 | Rib-X Pharmaceuticals, Inc. | Macrolide compounds and methods of making and using the same |
| EP2176216B1 (en) * | 2007-07-06 | 2012-04-25 | Paratek Pharmaceuticals, Inc. | Methods for synthesizing 9-substituted minocycline |
| JP2011026260A (ja) * | 2009-07-28 | 2011-02-10 | Central Glass Co Ltd | ３位に脱離基を有する２−フルオロプロピルアミン保護体または該アミンｎ−アルキル保護体 |
| CN101619085B (zh) * | 2009-08-11 | 2015-04-22 | 沈阳药科大学 | 红霉素衍生物及其作为肿瘤细胞增殖抑制剂的用途 |
| AR092278A1 (es) * | 2012-08-31 | 2015-04-08 | Novartis Ag | Proceso de obtencion de derivados n-acilicos de bifenil-alanina e intermediarios relacionados |
| HK1244211A1 (zh) | 2014-11-14 | 2018-08-03 | Melinta Therapeutics, Inc. | 治疗、预防或降低皮肤感染风险的方法 |
| WO2018191682A1 (en) * | 2017-04-15 | 2018-10-18 | Melinta Therapeutics, Inc. | Triazole compounds and methods of making and using the same |
| CN110108826A (zh) * | 2019-05-24 | 2019-08-09 | 内蒙古蒙牛乳业（集团）股份有限公司 | 乳或乳制品中氟苯尼考胺的检测方法 |
| US20210371389A1 (en) * | 2020-04-24 | 2021-12-02 | Kansas Soybean Commission | One-step synthesis of soybean polyols |
| WO2022146980A1 (en) | 2020-12-28 | 2022-07-07 | Georgia Tech Research Corporation | Compositions and methods for inhibiting fibrosis, inflammation and cancer |
| CN115745823B (zh) * | 2022-11-03 | 2024-02-23 | 武夷学院 | 一种化合物的制备方法及其应用 |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3725385A (en) | 1970-11-02 | 1973-04-03 | Abbott Lab | Process for the demethylation of 3-amino macrolides |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| MY113693A (en) | 1992-05-26 | 2002-05-31 | Chugai Pharmaceutical Co Ltd | Erythromycin derivatives having an enterokinesis stimulating action |
| US6927057B2 (en) | 1993-09-20 | 2005-08-09 | Kosan Biosciences | Macrolide analogs |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| DE19604223A1 (de) * | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
| DK1025114T3 (da) * | 1997-09-30 | 2004-07-05 | Abbott Lab | 3'-N-modificerede 6-O-substituerede erythromycin-ketolidderivater med antibakteriel aktivitet |
| US6124269A (en) | 1997-10-29 | 2000-09-26 | Abbott Laboratories | 2-Halo-6-O-substituted ketolide derivatives |
| ZA989885B (en) | 1997-10-31 | 1999-05-05 | Abbott Lab | Use of macrolides for the treatment of cancer and macular degeneration |
| WO1999063929A2 (en) | 1998-06-08 | 1999-12-16 | Advanced Medicine, Inc. | Multibinding inhibitors of microsomal triglyceride transferase protein |
| IT1301968B1 (it) | 1998-07-30 | 2000-07-20 | Zambon Spa | Derivati di eritromicina ad attivita' antibiotica |
| GB9821938D0 (en) | 1998-10-09 | 1998-12-02 | Zeneca Ltd | Chemical compounds |
| HRP980646B1 (en) | 1998-12-30 | 2008-02-29 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | Novel oleandomycin derivatives |
| US6514944B2 (en) | 1999-04-16 | 2003-02-04 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
| US6939861B2 (en) | 1999-04-16 | 2005-09-06 | Kosan Biosciences, Inc. | Amido macrolides |
| US6451768B1 (en) | 1999-04-16 | 2002-09-17 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
| US6413981B1 (en) | 1999-08-12 | 2002-07-02 | Ortho-Mcneil Pharamceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| EP1101769A3 (en) | 1999-11-18 | 2001-10-24 | Pfizer Products Inc. | Nitrogen containing erythromycin derivatives |
| GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
| JP2003522763A (ja) | 2000-02-10 | 2003-07-29 | ファルマシア・アンド・アップジョン・カンパニー | ピペラジンアミド置換基を持つオキサゾリジノンチオアミド |
| CA2399198A1 (en) | 2000-02-18 | 2001-08-23 | Christopher Carreras | Motilide compounds |
| GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| ATE321770T1 (de) | 2000-08-17 | 2006-04-15 | Kitasato Inst | Pseudoerythromycin-derivate |
| BR0113472A (pt) | 2000-08-22 | 2003-07-01 | Basilea Pharmaceutica Ag | Macrolìdeos com atividade antibacteriana |
| AU2002225724A1 (en) | 2000-12-01 | 2002-07-08 | Kosan Biosciences, Inc. | Motilide compounds |
| WO2003004509A2 (en) | 2001-07-03 | 2003-01-16 | Chiron Corporation | C12 modified erythromycin macrolides and ketolides having antibacterial activity |
| US7396847B2 (en) | 2001-09-11 | 2008-07-08 | Astrazeneca Ab | Oxazolidinone and/or isoxazoline as antibacterial agents |
| EP1443930A1 (en) | 2001-10-25 | 2004-08-11 | AstraZeneca AB | Isoxazoline derivatives useful as antimicrobials |
| JP2005538927A (ja) | 2002-01-17 | 2005-12-22 | コーザン バイオサイエンシス インコーポレイテッド | アミドマクロライド |
| US8063021B2 (en) | 2002-01-17 | 2011-11-22 | Kosan Biosciences Incorporated | Ketolide anti-infective compounds |
| US6992069B2 (en) | 2002-04-30 | 2006-01-31 | Yu-Gui Gu | Tricyclic macrolide antibacterial compounds |
| US20050045585A1 (en) * | 2002-05-07 | 2005-03-03 | Gang Zhang | Method of electrochemically fabricating multilayer structures having improved interlayer adhesion |
| AU2003240482B2 (en) * | 2002-05-30 | 2009-03-12 | The Scripps Research Institute | Copper-catalysed ligation of azides and acetylenes |
| ITMI20021726A1 (it) | 2002-08-01 | 2004-02-02 | Zambon Spa | Macrolidi ad attivita' antiinfiammatoria. |
| AR043050A1 (es) * | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos |
| CN1780846A (zh) | 2003-03-05 | 2006-05-31 | Rib－X医药品有限公司 | 双官能杂环化合物及其制备和使用方法 |
| WO2004078771A1 (ja) | 2003-03-07 | 2004-09-16 | Taisho Pharmaceutical Co., Ltd. | ２－フルオロ－６－ｏ－置換ケトライド誘導体 |
| ES2552682T3 (es) | 2003-03-10 | 2015-12-01 | Merck Sharp & Dohme Corp. | Agentes antibacterianos novedosos |
| US7163924B2 (en) | 2003-04-25 | 2007-01-16 | Chiron Corporation | Ketolide derivatives |
| US7332476B2 (en) | 2003-04-25 | 2008-02-19 | Novartis Ag | Pyridyl substituted ketolide antibiotics |
| JP5043428B2 (ja) * | 2003-06-03 | 2012-10-10 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | ビアリール複素環式化合物ならびにその製造および使用方法 |
| WO2005042554A1 (en) | 2003-10-30 | 2005-05-12 | Rib-X Pharmaceuticals, Inc. | Bifunctional macrolide heterocyclic compounds and methods of making and using the same |
| JP2007512256A (ja) | 2003-11-18 | 2007-05-17 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | 二官能性マクロライド複素環化合物ならびにこれらを製造する方法およびこれらを使用する方法 |
| WO2005067919A1 (en) | 2003-12-24 | 2005-07-28 | Enanta Pharmaceuticals, Inc. | 11-csubsituted erythromycin derivatives |
| JP5383037B2 (ja) * | 2004-02-27 | 2014-01-08 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | 大環状化合物およびそれらを製造し使用する方法 |
| WO2005118610A2 (en) | 2004-06-01 | 2005-12-15 | Rib-X Pharmaceuticals, Inc. | Macrocyclic compounds and methods of making and using the same |
| US7402568B2 (en) | 2004-09-29 | 2008-07-22 | Enanta Pharmaceuticals, Inc. | Bicyclic 9a-azalide derivatives |
| US7419962B2 (en) | 2004-12-07 | 2008-09-02 | Enanta Pharmaceuticals, Inc. | 3,6-bicyclolides |
| US7229972B2 (en) | 2004-12-07 | 2007-06-12 | Enanta Pharmaceuticals, Inc. | 3,6-Bicyclolides |
| US7312201B2 (en) | 2004-12-13 | 2007-12-25 | Enanta Pharmaceuticals, Inc. | Tetracyclic bicyclolides |
| UA85937C2 (uk) | 2004-12-21 | 2009-03-10 | Пфайзер Продактс Інк. | Макроліди |
| US7271155B2 (en) | 2005-01-07 | 2007-09-18 | Enanta Pharmaceuticals, Inc. | 9A, 11-2C-bicyclic 9a-azalide derivatives |
| EP3290427A1 (en) * | 2005-08-24 | 2018-03-07 | Melinta Therapeutics, Inc. | Triazole compounds and methods of making and using the same |
| JP2009506063A (ja) * | 2005-08-24 | 2009-02-12 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
-
2006
- 2006-08-24 EP EP17178221.2A patent/EP3290427A1/en not_active Withdrawn
- 2006-08-24 EP EP06824847A patent/EP1928893A2/en not_active Withdrawn
- 2006-08-24 HR HRP20171285TT patent/HRP20171285T1/hr unknown
- 2006-08-24 DK DK06802533.7T patent/DK1934238T3/en active
- 2006-08-24 WO PCT/US2006/033645 patent/WO2007025284A1/en not_active Ceased
- 2006-08-24 JP JP2008528247A patent/JP5395432B2/ja not_active Expired - Fee Related
- 2006-08-24 ES ES06802533T patent/ES2638427T3/es active Active
- 2006-08-24 JP JP2008528168A patent/JP2009506066A/ja not_active Withdrawn
- 2006-08-24 EP EP06802533.7A patent/EP1934238B1/en not_active Not-in-force
- 2006-08-24 US US11/990,883 patent/US8278281B2/en not_active Expired - Fee Related
- 2006-08-24 WO PCT/US2006/033170 patent/WO2007025098A2/en not_active Ceased
-
2012
- 2012-09-14 US US13/616,962 patent/US20130065845A1/en not_active Abandoned
-
2013
- 2013-08-19 JP JP2013169594A patent/JP5981401B2/ja not_active Expired - Fee Related
- 2013-08-21 US US13/972,732 patent/US9006189B2/en not_active Expired - Fee Related
-
2015
- 2015-03-18 US US14/661,863 patent/US20160031926A1/en not_active Abandoned
- 2015-11-16 JP JP2015223733A patent/JP2016094421A/ja active Pending
-
2017
- 2017-05-17 US US15/597,701 patent/US20180094016A1/en not_active Abandoned
- 2017-07-21 JP JP2017141745A patent/JP2018008970A/ja active Pending
-
2018
- 2018-09-11 JP JP2018169395A patent/JP2019023194A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009506066A5 (https=) | ||
| JP2007525520A5 (https=) | ||
| CA2566544C (en) | Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases | |
| JP2009506075A5 (https=) | ||
| AU2014208965B2 (en) | Compounds and methods for treating bacterial infections | |
| WO2016161361A4 (en) | Compositions and methods of targeting mutant k-ras | |
| JP2004500384A (ja) | アザライド系抗生物質組成物 | |
| JP2012506870A (ja) | 胃腸疾患を治療するための方法 | |
| JP2009506063A5 (https=) | ||
| RS52808B (sr) | Kinolinski derivati kao antibakterijski agensi | |
| EP1167375A1 (en) | Erythromycin derivatives | |
| WO2005007143A2 (en) | Use of makrolides and ketolides for the treatment of tuberculosis | |
| KR20150006080A (ko) | 항생제 내성 세균 감염의 치료 | |
| KR20110050623A (ko) | 항생제 | |
| CN115461353B (zh) | 免疫调节o-het/芳基氮环内酯 | |
| JP2007509980A5 (https=) | ||
| CN117105930B (zh) | 一类3,13-双取代小檗碱衍生物及其制备方法和应用 | |
| CN105524132B (zh) | 含有喹啉取代基的红霉素a酮内酯类抗生素衍生物、其制备方法及应用 | |
| KR102488654B1 (ko) | 마크로코신 화합물을 포함하는 약학적 조성물 및 마크로코신 화합물의 제조방법 | |
| Zhong et al. | In vivo pharmacokinetic and pharmacodynamic profiles of orbifloxacin against Staphylococcus aureus in a neutropenic murine thigh infection model | |
| JP2007512256A5 (https=) | ||
| CN103709177B (zh) | 利福霉素类沃尼妙林杂合抗生素及其制备方法 | |
| Asif et al. | An overview on antitubercular activities of fluoroquinolones and other related analogues | |
| EP4342484A1 (en) | Pharmaceutical composition comprising macrocosine compound and method for preparing macrocosine compound | |
| CN101189222B (zh) | 三-、四-取代-3-氨基吡咯烷衍生物 |